Prenetics acquires Oxsed to advance rapid Covid-19 test development
Oxsed is engaged in developing a rapid diagnostic testing platform for the in vitro qualitative detection of SARS-CoV-2
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Nov 20
Oxsed is engaged in developing a rapid diagnostic testing platform for the in vitro qualitative detection of SARS-CoV-2
30 Oct 20
The cobas EGFR Mutation Test v2 is an FDA approved companion diagnostic for the detection of EGFR mutations…
30 Oct 20
Through this partnership, Thermo Fisher will have the first option to produce new technologies developed by the TIC…
30 Oct 20
Leveraging technology developed and licensed from ST, Alifax is manufacturing the Molecular Mouse, a small portable instrument that…
30 Oct 20
The new consortium will use SARS-CoV-2 Direct Antigen Rapid Test (DART) test from E25Bio which provides results in…
30 Oct 20
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare
29 Oct 20
ViraxClear has received an initial cash deposit for their Test Kits for the Chilean market with a contract…
29 Oct 20
The assay runs on a single MassARRAY instrument, a high-sensitive mass spectrometry-based platform used for high-throughput genetic analysis
29 Oct 20
Diagnostic Solutions Company Expands Offering as Medical Experts Warn of 'Perfect Storm' of Escalating Respiratory Infections
28 Oct 20
As part of the company's wide variety of COVID-19 kits, the VTM is equipped with a 15 ml…